Abstract:Protection from boosting with updated SARS-CoV-2 vaccines containing emerging Omicron sub-variants like BA.1 or BA.5 was not satisfying, especially the neutralizing ability against the newly emerged BQ and XBB related variants. Similar with influenza virus, antigenic drift is highly relevant to SARS-CoV-2 evolution, and immune imprinting may limit the performance of updated vaccines. In this study, we investigated whether repeated infection with Omicron variant could reduce the immune imprinting. A total of 194 participants with different status of vaccination (unvaccinated, regular vaccination and booster vaccination) confirmed for first infection and re-infection with BA.5, BF.7 and XBB variants were enrolled, and the neutralizing profiles against wild type (WT) SARS-CoV-2 and Omicron sub-variants were analyzed. The results showed that neutralizing potency against the corresponding infected variant is significantly hampered along with the doses of vaccination during first infection. However, for the participants with first infection of BA.5/BF.7 variants and re-infection of XBB variant, immune imprinting was obviously alleviated, indicated as significantly increased ratio of the corresponding infected variant/WT ID 50 titers and higher percentage of samples with high neutralizing activities (ID 50 > 500) against BA.5, BF.7 and XBB variants. Moreover, repeated Omicron infection could induce strong neutralizing potency with broad neutralizing profiles against a series of other Omicron sub-variants including the newly emerged EG.5.1 variant, both in the vaccine naïve and vaccine experienced individuals. In conclusion, our results provide useful information for the antigen selection and vaccination strategies, and indicated that repeated boosting vaccination with Omicron based vaccines especially the XBB sub-variant without the WT spike protein might achieve broad and efficient antibody responses against Omicron variant.

Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1

Repeated Omicron Infection Dampens Immune Imprinting from Vaccination and Induces Broad Neutralizing Profiles Against Other Omicron Sub-Variants

B cells imprinted by ancestral SARS-CoV-2 develop pan-sarbecovirus neutralization in immune recalls

Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals

Omicron-specific naive B cell maturation alleviates immune imprinting induced by SARS-CoV-2 inactivated vaccine

Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections

Repeated Omicron Infection Dampens Immune Imprinting from Previous Vaccination and Induces Broad Neutralizing Antibodies Against Omicron Sub-Variants

Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine

Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations

Immune recall improves antibody durability and breadth to SARS-CoV-2 variants

Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

Primary Exposure to SARS-CoV-2 Variants Elicits Convergent Epitope Specificities, Immunoglobulin V Gene Usage and Public B Cell Clones

Prolonged Omicron-specific B cell maturation alleviates immune imprinting induced by SARS-CoV-2 inactivated vaccine

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike